112 related articles for article (PubMed ID: 3816915)
41. [Frequency and significance of lymphoplasmocyte infiltration in human gliomas (author's transl)].
Schiffer D; Croveri G; Pautasso C
Tumori; 1974; 60(3):177-84. PubMed ID: 4372756
[No Abstract] [Full Text] [Related]
42. In vitro generation and antitumor activity of adherent lymphokine-activated killer cells from the blood of patients with brain tumors.
Whiteside TL; Wang YL; Selker RG; Herberman RB
Cancer Res; 1988 Nov; 48(21):6069-75. PubMed ID: 2971433
[TBL] [Abstract][Full Text] [Related]
43. Generation of cytotoxic immune responses against a rat glioma by in vivo priming and secondary in vitro stimulation with tumor cells.
Holladay FP; Lopez G; De M; Morantz RA; Wood GW
Neurosurgery; 1992 Apr; 30(4):499-504; discussion 504-5. PubMed ID: 1584347
[TBL] [Abstract][Full Text] [Related]
44. Autologous serologic responses in glioma patients. Correlation with tumor grade and survival.
Kornblith PL; Coakham HB; Pollock LA; Wood WC; Green SB; Smith BH
Cancer; 1983 Dec; 52(12):2230-5. PubMed ID: 6640493
[TBL] [Abstract][Full Text] [Related]
45. Carcinoembryonic antigen in patients with intracranial tumors.
Suzuki Y; Tanaka R
J Neurosurg; 1980 Sep; 53(3):355-60. PubMed ID: 7420150
[TBL] [Abstract][Full Text] [Related]
46. [The anti-tumor efficacy of lymphokine-activated killer (LAK) cells induced in vitro from peripheral blood lymphocytes of patients with malignant glioma].
Shimizu K; Miyao Y; Okamoto Y; Matsui Y; Ushio Y; Tsuda N; Hayakawa T; Ishida N; Mogami H
No To Shinkei; 1986 Mar; 38(3):265-71. PubMed ID: 3085695
[TBL] [Abstract][Full Text] [Related]
47. [Immunohistological diagnosis of human and experimental brain tumors using antiserum to astroprotein (author's transl)].
Yoshimine T; Ushio Y; Hayakawa T; Morimoto K; Mori T; Mogami H
No To Shinkei; 1979 Jan; 31(1):85-93. PubMed ID: 371641
[No Abstract] [Full Text] [Related]
48. [Histopathology of glioma relapses].
Arendt A
Zentralbl Allg Pathol; 1982; 126(5-6):499-504. PubMed ID: 7158103
[TBL] [Abstract][Full Text] [Related]
49. Defining an Intermediate-risk Group for Low-grade Glioma: A National Cancer Database Analysis.
Jairam V; Kann BH; Park HS; Miccio JA; Beckta JM; Yu JB; Prabhu RS; Gao SJ; Mehta MP; Curran WJ; Bindra RS; Contessa JN; Patel KR
Anticancer Res; 2019 Jun; 39(6):2911-2918. PubMed ID: 31177129
[TBL] [Abstract][Full Text] [Related]
50. [The mesenchymal defense reaction in the brain of the golden hamster after transplantation of human cerebral tumors].
Schmidt H; Kleinecke G; Goldenberg DM
Z Krebsforsch; 1968; 71(4):308-15. PubMed ID: 4304080
[No Abstract] [Full Text] [Related]
51. Histological grading of gliomas.
Daumas-Duport C
Curr Opin Neurol Neurosurg; 1992 Dec; 5(6):924-31. PubMed ID: 1334739
[TBL] [Abstract][Full Text] [Related]
52. Invariant natural killer T cells are preserved in patients with glioma and exhibit antitumor lytic activity following dendritic cell-mediated expansion.
Dhodapkar KM; Cirignano B; Chamian F; Zagzag D; Miller DC; Finlay JL; Steinman RM
Int J Cancer; 2004 May; 109(6):893-9. PubMed ID: 15027123
[TBL] [Abstract][Full Text] [Related]
53. Descriptive epidemiology of cerebral gliomas in France.
Fleury A; Menegoz F; Grosclaude P; Daures JP; Henry-Amar M; Raverdy N; Schaffer P; Poisson M; Delattre JY
Cancer; 1997 Mar; 79(6):1195-202. PubMed ID: 9070498
[TBL] [Abstract][Full Text] [Related]
54. Immune stimulatory effects of CD70 override CD70-mediated immune cell apoptosis in rodent glioma models and confer long-lasting antiglioma immunity in vivo.
Aulwurm S; Wischhusen J; Friese M; Borst J; Weller M
Int J Cancer; 2006 Apr; 118(7):1728-35. PubMed ID: 16217761
[TBL] [Abstract][Full Text] [Related]
55. [Improvement of host-immunity by adjuvant therapy with juzen-taiho-to for patients with brain tumors].
Miyagami M; Katayama Y
No Shinkei Geka; 2003 Apr; 31(4):401-9. PubMed ID: 12704821
[TBL] [Abstract][Full Text] [Related]
56. Some characteristics of gliomas managed at a Neurosurgery centre in Nigeria.
Ndubuisi CA; Ohaegbulam SC; Chikani MO; Mezue WC; Mbadugha T; Okhueleigbe M
Niger Postgrad Med J; 2017; 24(1):44-47. PubMed ID: 28492209
[TBL] [Abstract][Full Text] [Related]
57. [Interstitial radiosurgery of low grade glioma].
Kreth FW; Warnke PC; Ostertag CB
Nervenarzt; 1993 Oct; 64(10):633-9. PubMed ID: 8232676
[TBL] [Abstract][Full Text] [Related]
58. [Immunology of the central nervous system and brain tumors].
Tybor K
Neurol Neurochir Pol; 1992; 26(6):853-9. PubMed ID: 1301513
[TBL] [Abstract][Full Text] [Related]
59. Metachronous, multicentric glioma of pilocytic astrocytoma with oligodendroglioma-like component and oligodendroglioma through distinct genetic aberrations.
Kanoke A; Kanamori M; Kumabe T; Saito R; Watanabe M; Tominaga T
J Neurosurg; 2013 Apr; 118(4):854-8. PubMed ID: 23082883
[TBL] [Abstract][Full Text] [Related]
60. Natural killer activity against cultured human neural tumor and fetal brain cells.
Yates AJ; Icard-Liepkalns C; Sirinek LP; Stephens RE; Elder PJ; Liepkalns VA; Whisler RL
Cell Immunol; 1985 Feb; 90(2):485-92. PubMed ID: 2981642
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
